Award recordCONTRACT

PACIFIC COMPOUNDING PHARMACY AND CONSULTATIONS, INC

PIID 36C26122N0168· VHA· 261-NETWORK CONTRACT OFFICE 21 (36C261)· Q517 · MEDICAL- PHARMACOLOGY· FY2022· $267,735 net obligations· UEI HSMVMGFMYZR9· CA

Description

IN SCOPE FUNDING INCREASE PHARMACEUTICAL COMPOUNDING BPA

Base award description: OY PHARMACEUTICAL COMPOUNDING BPA

First action · last action
2021-12-06 · 2023-05-07
Transactions
5
First transaction's obligation
$165,620
Base + all options value (sum of deltas)
$267,735
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
2
SDVOSB flag on record
No
Parent IDV
36C26120A0009
NAICS
446110 · PHARMACIES AND DRUG STORES

Modification chain · 5 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$395,450$0Base award · 2021-12-06 · this action $165,620 · running total $165,620Modification P00001 · 2021-12-06 · this action $35,930 · running total $201,550Modification P00002 · 2022-08-24 · this action $66,025 · running total $267,575Modification P00004 · 2022-10-17 · this action $127,875 · running total $395,450Modification P00005 · 2023-05-07 · this action -$127,715 · running total $267,735
  • Base2021-12-06+$165,620= $165,620
  • Mod P000012021-12-06+$35,930= $201,550
  • Mod P000022022-08-24+$66,025= $267,575
  • Mod P000042022-10-17+$127,875= $395,450
  • Mod P000052023-05-07-$127,715= $267,735
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2021-12-06+$165,620$165,620OY PHARMACEUTICAL COMPOUNDING BPA
Mod P00001· FUNDING ONLY ACTION2021-12-06+$35,930$201,550IN SCOPE FUNDING INCREASE PHARMACEUTICAL COMPOUNDING BPA
Mod P00002· FUNDING ONLY ACTION2022-08-24+$66,025$267,575IN SCOPE FUNDING INCREASE PHARMACEUTICAL COMPOUNDING BPA
Mod P00004· FUNDING ONLY ACTION2022-10-17+$127,875$395,450IN SCOPE FUNDING INCREASE PHARMACEUTICAL COMPOUNDING BPA
Mod P00005· FUNDING ONLY ACTION2023-05-07−$127,715$267,735IN SCOPE FUNDING INCREASE PHARMACEUTICAL COMPOUNDING BPA

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI HSMVMGFMYZR9)

AwardOffice · PSC / listingNet obligationsFY
36C26125P0271261-NETWORK CONTRACT OFFICE 21 (36C261) · Q501 · MEDICAL- ANESTHESIOLOGY$149,965FY2025
36C26124N0350261-NETWORK CONTRACT OFFICE 21 (36C261) · Q517 · PHARMACY SERVICES$297,325FY2024
36C26123N0232261-NETWORK CONTRACT OFFICE 21 (36C261) · Q517 · MEDICAL- PHARMACOLOGY$295,970FY2023
36C26121N0261261-NETWORK CONTRACT OFFICE 21 (36C261) · Q517 · MEDICAL- PHARMACOLOGY$225,085FY2021
36C26120N0280261-NETWORK CONTRACT OFFICE 21 (36C261) · Q517 · MEDICAL- PHARMACOLOGY$357,825FY2020
36C26120A0009261-NETWORK CONTRACT OFFICE 21 (36C261) · Q517 · MEDICAL- PHARMACOLOGY$0FY2020

Other recipients under Q517 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26126P0986L1 ENTERPRISES INCORPORATED261-NETWORK CONTRACT OFFICE 21 (36C261)$44,920FY2026
36C26126P0904UNITED RETURNS, INC.261-NETWORK CONTRACT OFFICE 21 (36C261)$18,000FY2026
36C26126N0541PALISADE-HERITAGE JV LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$300,000FY2026
36C26126P0822PHARMALINK INC261-NETWORK CONTRACT OFFICE 21 (36C261)$11,750FY2026
36C26126P0561PHARMALINK INC261-NETWORK CONTRACT OFFICE 21 (36C261)$36,000FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26122N0168_3600_36C26120A0009_3600 · retrieved 2026-09-26.